Bausch Health Companies (BHC) Net Income (2009 - 2026)
Bausch Health Companies (BHC) posted Net Income of $260.0 million for Q2 2026, up 118.17% sequentially from -$1.4 billion in Q1 2026, and up 103.12% YoY from $128.0 million in Q2 2025.
Bausch Health Companies (BHC) Net Income (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Net Income for 18 years, with the latest figure at $260.0 million in Q2 2026.
- Quarterly Net Income rose 103.12% year-over-year to $260.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.1 billion (down 2377.08% YoY) and the FY2025 annual result came in at $120.0 million, up 266.67% from the prior year.
- Net Income grew to $260.0 million in Q2 2026 per BHC's latest filing, from -$1.4 billion in the prior quarter.
- Over five years, Net Income peaked at $403.0 million in Q3 2022 and troughed at -$1.4 billion in Q1 2026.
- A 5-year average of -$108.1 million and a median of -$71.5 million in 2022 frame the typical range for Net Income.
- The sharpest annual moves came in 2025 and 2026: Net Income surged 12900.0% in 2025, then slumped 1563.95% in 2026.
- Over 5 years, Net Income stood at -$410.0 million in 2022, then surged by 88.54% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then sank by 205.1% to -$103.0 million in 2025, then surged by 352.43% to $260.0 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered $260.0 million, -$1.4 billion, and -$103.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -69.36 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.57 Bn | 730.75 Mn | 2.10 Bn | 260.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 260.00 Mn |
| Mar 31, 2026 | -1.43 Bn |
| Dec 31, 2025 | -103.00 Mn |
| Sep 30, 2025 | 181.00 Mn |
| Jun 30, 2025 | 128.00 Mn |
| Mar 31, 2025 | -86.00 Mn |
| Dec 31, 2024 | 98.00 Mn |
| Sep 30, 2024 | -92.00 Mn |
| Jun 30, 2024 | -1.00 Mn |
| Mar 31, 2024 | -77.00 Mn |
| Dec 31, 2023 | -47.00 Mn |
| Sep 30, 2023 | -382.00 Mn |
| Jun 30, 2023 | 27.00 Mn |
| Mar 31, 2023 | -209.00 Mn |
| Dec 31, 2022 | -410.00 Mn |
| Sep 30, 2022 | 403.00 Mn |
| Jun 30, 2022 | -139.00 Mn |
| Mar 31, 2022 | -66.00 Mn |
| Dec 31, 2021 | 72.00 Mn |
| Sep 30, 2021 | 191.00 Mn |